Raffles Medical (RFMD SP): 2022 Result Tops Expectation; Medical Tourism Resumption to Drive Growth
Raffles reported significant margin improvement in 2022. Driven by medical tourism resumption and China opening, the company is expected to see...
424 Views
Thomson Medical (TMG SP)/Tmc Life Sciences (TMCL MK): Strong H1 Result Driven By Continued Recovery
Thomson Medical reported 27% revenue growth in H1FY23, driven by increase in patient loads and higher average bill sizes. Increased capacity and...
507 Views
Thomson Medical (TMG SP)/Tmc Life Sciences (TMCL MK): Strong Recovery; Scale Expansion to Aid Growth
Thomson Medical, with predominant focus on gynecology and pediatrics, is well-positioned to benefit from Singapore and Malaysia re-opening. Recent...
691 Views
Highest-Yielding Billionaire Plays on SGX
There are 89 primary-listed stocks on the SGX with market capitalisation above S$1 billion, of which 29 are in the S-REITs and Property Trusts...
444 Views
Key Singapore Market Moves and Flows in 3Q21
In 3Q21, the STI saw its narrowest quarterly trading range since 3Q17, generating a 0.2% decline in total return, while the FTSE APAC Index...
1.2k Views